These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2775921)

  • 1. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture.
    Barnett MJ; Eaves CJ; Phillips GL; Kalousek DK; Klingemann HG; Lansdorp PM; Reece DE; Shepherd JD; Shaw GJ; Eaves AC
    Bone Marrow Transplant; 1989 Jul; 4(4):345-51. PubMed ID: 2775921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
    Barnett MJ; Eaves CJ; Phillips GL; Hogge DE; Klingemann HG; Lansdorp PM; Nantel SH; Reece DE; Shepherd JD; Sutherland HJ
    Stem Cells; 1993 Oct; 11 Suppl 3():64-6. PubMed ID: 7905324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cultured bone marrow cells in autologous transplantation.
    Coutinho LH; Testa NG; Chang J; Morgenstern G; Harrison C; Dexter TM
    Prog Clin Biol Res; 1990; 333():415-32; discussion 433. PubMed ID: 2408062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of autotransplants in chronic myeloid leukaemia.
    Goldman JM; Deisseroth AB
    Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study.
    Coutinho LH; Chang J; Brereton ML; Morgenstern GR; Scarffe JH; Harrison CJ; Yin JA; Darbyshire PJ; Burdach S; Dexter TM; Testa NG
    Bone Marrow Transplant; 1997 May; 19(10):969-76. PubMed ID: 9169640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
    Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM
    Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Cottafavi L; Dotti GP; Rizzoli V
    Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
    Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
    Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
    O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
    Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM
    Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous transplant for CML revisited.
    Daley GQ; Goldman JM
    Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
    Frassoni F; Giordano D; Podestà M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.